From: Discussion

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Intervention | Function Short-Term Effect Size SOE | Function Intermediate-Term Effect Size SOE | Function Long-Term Effect Size SOE | Pain Short-Term Effect Size SOE | Pain Intermediate-Term Effect Size SOE | Pain Long-Term Effect Size SOE |
---|---|---|---|---|---|---|
Exercise: Versus Paroxetine | no evidence | no evidence | no evidence | no evidence | insufficient evidence | no evidence |
CBT Plus Amitriptyline: Versus Amitriptyline | insufficient evidence | no evidence | no evidence | insufficient evidence | no evidence | no evidence |
Biofeedback: Versus Escitalopram | insufficient evidence | no evidence | no evidence | insufficient evidence | no evidence | no evidence |
CBT: Versus Pregabalin; Duloxetine | no evidence | smallb + | no evidence | no evidence | noneb + | no evidence |
Short-Term: 1 to <6 months; Intermediate-Term: ≥6 to <12 months; Long-Term: ≥12 months
Effect Size: none, small, moderate, or large improvement
Strength of Evidence: + = low, ++ = moderate, +++ = high
SOE and effect size based on totality of evidence from prior report and new trials
New trial did not change effect size or SOE
From: Discussion
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.